Phase 2 study of dostarlimab plus niraparib in stage III-IV recurrent or refractory Penile squamous cell carcinoma
多斯利单抗联合尼拉帕尼治疗III-IV期复发或难治性阴茎鳞状细胞癌的II期研究
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2577632
Hatoum, Firas; Souza, Gabriel Roman; Johnson, Jeff; Miller, Justin; Fazili, Adnan; Pettaway, Curtis Alvin; Campbell, Matthew T; Neubauer, Robin; Johns, Andrew; Mizelle, Sarah Raymond; Kim, Youngchul; Chadha, Juskaran; Zhang, Jingsong; Jameel, Ghazal; Oschmann, Erika; Dhillon, Jasreman; Moscu, Anay; Janeway, Ryan; Harris, Walt; Lu, Xin; Spiess, Philippe E; Chahoud, Jad